Delirium, Dementia, Amnestic, Cognitive Disorders  >>  PRX-03140  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PRX-03140 / Resilience
NCT00384423: Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept

Completed
2a
80
US
PRX-03140
Epix Pharmaceuticals, Inc.
Alzheimer's Disease
10/07
 
NCT00672945: A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil

Terminated
2
420
US
PRX-03140, Placebo
Epix Pharmaceuticals, Inc.
Alzheimer's Disease
01/10
 
NCT00693004: Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease

Terminated
2
236
US
PRX-03140, Donepezil, Placebo
Epix Pharmaceuticals, Inc.
Alzheimer's Disease
01/10
 

Download Options